Michael Yu

PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity

Junjian Liu, H. Shen, Min Wu, 2021, Oncoimmunology.

Structure of IgG-Fc hexamer reveals a mutual lock-and-key mode of Fc-Fc interaction

Xiaodong Xiao, Zhihai Wu, Bingliang Chen, 2022, bioRxiv.

Development and characterization of a novel anti-OX40 antibody for potent immune activation

Junjian Liu, Dongdong Wu, B. Prinz, 2020, Cancer Immunology, Immunotherapy.

Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody

Junjian Liu, Ya-Wei Xiong, B. Prinz, 2021, Cancer Immunology, Immunotherapy.

Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance

W. Liang, Jincun Zhao, Junjian Liu, 2022, The Journal of clinical investigation.